๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prophylaxis Against Hepatitis B Recurrence Posttransplantation Using Lamivudine and Individualized Low-Dose Hepatitis B Immunoglobulin

โœ Scribed by L. Jiang; L. Yan; B. Li; T. Wen; J. Zhao; L. Jiang; N. Cheng; Y. Wei; J. Yang; M. Xu; W. Wang

Book ID
114805670
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
345 KB
Volume
10
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prevention of hepatitis B recurrence aft
Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis
โœ Shusen Zheng; Yaomin Chen; Tingbo Liang; Anwei Lu; Weilin Wang; Yan Shen; Min Zh ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 1 views

The aim of our study was to determine the outcomes of liver transplant recipients receiving either lamivudine (LAM) monotherapy or LAM combined with low-dose intramuscular (IM) hepatitis B Immunoglobulin (HBIG) therapy. We performed a retrospective review of the medical records of patients that had

Prophylaxis against hepatitis B recurren
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
โœ Jay S. Markowitz; Paul Martin; Andrew J. Conrad; James F. Markmann; Philip Seu; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 52 KB

Patients undergoing liver transplantation for hepatitis B-related liver disease are prone to recurrence. The mainstay of prophylaxis has been passive immunotherapy with hepatitis B immune globulin (HBIG). Antiviral therapy with lamivudine has proven effective in lowering hepatitis B virus (HBV) DNA